Plus Therapeutics (PSTV) Other Non-Current Liabilities (2010 - 2025)
Plus Therapeutics (PSTV) reported Other Non-Current Liabilities of $25.1 million for Q1 2025, up 2513700.0% quarter-over-quarter from $1000.0 in Q4 2021.
Plus Therapeutics (PSTV) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
Plus Therapeutics (PSTV) has 9 years of Other Non-Current Liabilities data on file, last reported at $25.1 million in Q1 2025.
- Other Non-Current Liabilities for Q1 2025 came in at $25.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $25.1 million (changed N/A YoY), and the FY2021 annual result was $1000.0, down 85.71% from the prior year.
- Other Non-Current Liabilities improved to $25.1 million in Q1 2025 per PSTV's latest filing, from $1000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $25.1 million in Q1 2025 and troughed at $1000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 25.14 Mn |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 242,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Dec 31, 2019 | 6.93 Mn |
| Sep 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 424,000.00 |
| Mar 31, 2019 | 98,000.00 |
| Dec 31, 2018 | 46,000.00 |
| Sep 30, 2018 | 1.47 Mn |
| Dec 31, 2014 | 9.79 Mn |
| Sep 30, 2012 | 1.87 Mn |
| Jun 30, 2012 | 1.01 Mn |
| Mar 31, 2012 | 757,000.00 |
| Dec 31, 2011 | 627,000.00 |